# Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration

> **NCT07442669** · NA · NOT_YET_RECRUITING · sponsor: **Hackensack Meridian Health** · enrollment: 100 (estimated)

## Conditions studied

- Respiratory Distress Syndrome, Newborn
- Respiratory Distress Syndrome in Premature Infant

## Interventions

- **DIAGNOSTIC_TEST:** Lung ultrasound

## Key facts

- **NCT ID:** NCT07442669
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-02-28
- **Final completion:** 2028-03-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07442669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07442669, "Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07442669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*